The levels of native curcumin measured in plasma were low (7.32 ng/mL). Conclusions Curcumin was generally well-tolerated although three subjects on curcumin withdrew due to gastrointestinal symptoms. We were unable to demonstrate clinical or biochemical evidence of efficacy of Curcumin C3 ComplexÂ® in AD in this 24-week placebo-controlled trial although preliminary data suggest limited bioavailability of this compound. 